Blast Phase Chronic Myeloid Leukemia

Oncology

Prevalence

12.0 / 100K

Incidence

1.9 / 100K/yr

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Blast Phase Chronic Myeloid Leukemia?

There are 1 clinical trial targeting Blast Phase Chronic Myeloid Leukemia tracked by BioSniper.

What is the prevalence of Blast Phase Chronic Myeloid Leukemia?

The estimated prevalence of Blast Phase Chronic Myeloid Leukemia is approximately 12.0 per 100,000 population.

Deep-dive into Blast Phase Chronic Myeloid Leukemia

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Blast Phase Chronic Myeloid Leukemia — Drugs in Development & Clinical Trials | BioSniper